Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Squamous Cell Transformation of Primary Lung Adenocarcinoma in a Patient With EML4-ALK Fusion Variant 5 Refractory to ALK Inhibitors.

Gong J, Gregg JP, Ma W, Yoneda K, Moore EH, Daly ME, Zhang Y, Williams MJ, Li T.

J Natl Compr Canc Netw. 2019 Apr 1;17(4):297-301. doi: 10.6004/jnccn.2019.7291.

PMID:
30959466
2.

Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial.

Bezjak A, Paulus R, Gaspar LE, Timmerman RD, Straube WL, Ryan WF, Garces YI, Pu AT, Singh AK, Videtic GM, McGarry RC, Iyengar P, Pantarotto JR, Urbanic JJ, Sun AY, Daly ME, Grills IS, Sperduto P, Normolle DP, Bradley JD, Choy H.

J Clin Oncol. 2019 Apr 3:JCO1800622. doi: 10.1200/JCO.18.00622. [Epub ahead of print]

PMID:
30943123
3.

Is Breast-Conserving Therapy Appropriate for Male Breast Cancer Patients? A National Cancer Database Analysis.

Bateni SB, Davidson AJ, Arora M, Daly ME, Stewart SL, Bold RJ, Canter RJ, Sauder CAM.

Ann Surg Oncol. 2019 Feb 13. doi: 10.1245/s10434-019-07159-4. [Epub ahead of print]

PMID:
30761438
4.

Is the Importance of Heart Dose Overstated in the Treatment of Non-Small Cell Lung Cancer? A Systematic Review of the Literature.

Zhang TW, Snir J, Boldt RG, Rodrigues GB, Louie AV, Gaede S, McGarry RC, Urbanic JJ, Daly ME, Palma DA.

Int J Radiat Oncol Biol Phys. 2019 Jan 7. pii: S0360-3016(18)34226-3. doi: 10.1016/j.ijrobp.2018.12.044. [Epub ahead of print]

PMID:
30630029
5.

Tumor Control and Toxicity after SBRT for Ultracentral, Central, and Paramediastinal Lung Tumors.

Nguyen KNB, Hause DJ, Novak J, Monjazeb AM, Daly ME.

Pract Radiat Oncol. 2019 Mar;9(2):e196-e202. doi: 10.1016/j.prro.2018.11.005. Epub 2018 Nov 26.

PMID:
30496842
6.

Preclinical Development and First-in-Human Imaging of the Integrin αvβ6 with [18F]αvβ6-Binding Peptide in Metastatic Carcinoma.

Hausner SH, Bold RJ, Cheuy LY, Chew HK, Daly ME, Davis RA, Foster CC, Kim EJ, Sutcliffe JL.

Clin Cancer Res. 2019 Feb 15;25(4):1206-1215. doi: 10.1158/1078-0432.CCR-18-2665. Epub 2018 Nov 6.

PMID:
30401687
7.

Treatment outcomes in HPV-negative oropharyngeal cancer: Surgery plus radiotherapy vs. definitive chemoradiotherapy.

Rash D, Daly ME, Durbin-Johnson B, Vaughan AT, Chen AM.

Ear Nose Throat J. 2018 Aug;97(8):E1-E7.

PMID:
30138518
8.

Changes in Regional Ventilation During Treatment and Dosimetric Advantages of CT Ventilation Image Guided Radiation Therapy for Locally Advanced Lung Cancer.

Yamamoto T, Kabus S, Bal M, Bzdusek K, Keall PJ, Wright C, Benedict SH, Daly ME.

Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1366-1373. doi: 10.1016/j.ijrobp.2018.04.063. Epub 2018 May 4.

9.

Stereotactic Ablative Radiation Therapy Induces Systemic Differences in Peripheral Blood Immunophenotype Dependent on Irradiated Site.

McGee HM, Daly ME, Azghadi S, Stewart SL, Oesterich L, Schlom J, Donahue R, Schoenfeld JD, Chen Q, Rao S, Fragoso RC, Valicenti RK, Canter RJ, Maverakis EM, Murphy WJ, Kelly K, Monjazeb AM.

Int J Radiat Oncol Biol Phys. 2018 Aug 1;101(5):1259-1270. doi: 10.1016/j.ijrobp.2018.04.038. Epub 2018 Apr 22.

PMID:
29891204
10.

Locally Advanced Lung Cancer: Is It Time to Take Cardiac Protection Seriously in Radiation Planning?

Urbanic JJ, McGarry RC, Daly ME, Palma DA.

Int J Radiat Oncol Biol Phys. 2018 Apr 1;100(5):1091-1094. doi: 10.1016/j.ijrobp.2017.09.044. No abstract available.

PMID:
29722650
11.

Consolidative Thoracic Radiation and Serial Central Nervous System Imaging.

Daly ME.

Int J Radiat Oncol Biol Phys. 2018 May 1;101(1):6. doi: 10.1016/j.ijrobp.2018.01.106. No abstract available.

PMID:
29619977
12.

Surveillance imaging following definitive radiotherapy for non-small cell lung cancer: What is the clinical impact?

Dyer BA, Daly ME.

Semin Oncol. 2017 Oct;44(5):303-309. doi: 10.1053/j.seminoncol.2018.01.007. Epub 2018 Feb 9. Review.

13.

Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Guideline Summary.

Schneider BJ, Daly ME, Kennedy EB, Stiles BM.

J Oncol Pract. 2018 Mar;14(3):180-186. doi: 10.1200/JOP.2017.028894. Epub 2017 Dec 19. No abstract available.

PMID:
29257717
14.

Functional Outcomes After De-escalated Chemoradiation Therapy for Human Papillomavirus-Positive Oropharyngeal Cancer: Secondary Analysis of a Phase 2 Trial.

Hegde JV, Shaverdian N, Felix C, Wang PC, Veruttipong D, Hsu S, Riess JW, Rao SD, Daly ME, Chen AM.

Int J Radiat Oncol Biol Phys. 2018 Mar 1;100(3):647-651. doi: 10.1016/j.ijrobp.2017.10.045. Epub 2017 Nov 6.

PMID:
29246721
15.

Stereotactic Body Radiation Therapy Versus Surgery for Early Lung Cancer Among US Veterans.

Bryant AK, Mundt RC, Sandhu AP, Urbanic JJ, Sharabi AB, Gupta S, Daly ME, Murphy JD.

Ann Thorac Surg. 2018 Feb;105(2):425-431. doi: 10.1016/j.athoracsur.2017.07.048. Epub 2017 Nov 30.

PMID:
29198624
16.

Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Guideline.

Schneider BJ, Daly ME, Kennedy EB, Antonoff MB, Broderick S, Feldman J, Jolly S, Meyers B, Rocco G, Rusthoven C, Slotman BJ, Sterman DH, Stiles BM.

J Clin Oncol. 2018 Mar 1;36(7):710-719. doi: 10.1200/JCO.2017.74.9671. Epub 2017 Nov 6.

PMID:
29106810
17.

Patient-reported quality-of-life outcomes after de-escalated chemoradiation for human papillomavirus-positive oropharyngeal carcinoma: Findings from a phase 2 trial.

Hegde JV, Shaverdian N, Daly ME, Felix C, Wong DL, Rosove MH, Garst JH, Wang PC, Veruttipong D, Rao S, Fragoso RC, Riess JW, Steinberg ML, Chen AM.

Cancer. 2018 Feb 1;124(3):521-529. doi: 10.1002/cncr.30954. Epub 2017 Oct 17.

18.

Prophylactic Cranial Irradiation for Small Cell Lung Cancer: New Insights.

Daly ME, Palma DA.

Int J Radiat Oncol Biol Phys. 2017 Sep 1;99(1):3-5. doi: 10.1016/j.ijrobp.2017.05.006. Epub 2017 Aug 7. No abstract available.

PMID:
28816157
19.

Durable Local Control Following Concurrent Hypofractionated Chemoradiation for a Massive Inflammatory Breast Cancer Chest Wall Recurrence.

Dyer BA, Nguyen KNB, Shukla RP, Li T, Daly ME.

Cureus. 2017 Jun 21;9(6):e1379. doi: 10.7759/cureus.1379.

20.

Prospective radiotherapy for patients with oropharyngeal carcinoma - Authors' reply.

Chen AM, Beron PJ, Wong D, Rosove MH, Rao SD, Steinberg ML, Kupelian PA, Daly ME.

Lancet Oncol. 2017 Aug;18(8):e426. doi: 10.1016/S1470-2045(17)30534-X. Epub 2017 Jul 26. No abstract available.

PMID:
28759373
21.

Radiomics-based Assessment of Radiation-induced Lung Injury After Stereotactic Body Radiotherapy.

Moran A, Daly ME, Yip SSF, Yamamoto T.

Clin Lung Cancer. 2017 Nov;18(6):e425-e431. doi: 10.1016/j.cllc.2017.05.014. Epub 2017 May 25.

PMID:
28623121
22.

Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline.

Videtic GMM, Donington J, Giuliani M, Heinzerling J, Karas TZ, Kelsey CR, Lally BE, Latzka K, Lo SS, Moghanaki D, Movsas B, Rimner A, Roach M, Rodrigues G, Shirvani SM, Simone CB 2nd, Timmerman R, Daly ME.

Pract Radiat Oncol. 2017 Sep - Oct;7(5):295-301. doi: 10.1016/j.prro.2017.04.014. Epub 2017 Jun 5.

PMID:
28596092
23.

Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study.

Chen AM, Felix C, Wang PC, Hsu S, Basehart V, Garst J, Beron P, Wong D, Rosove MH, Rao S, Melanson H, Kim E, Palmer D, Qi L, Kelly K, Steinberg ML, Kupelian PA, Daly ME.

Lancet Oncol. 2017 Jun;18(6):803-811. doi: 10.1016/S1470-2045(17)30246-2. Epub 2017 Apr 20.

24.

Increasing Rates of No Treatment in Advanced-Stage Non-Small Cell Lung Cancer Patients: A Propensity-Matched Analysis.

David EA, Daly ME, Li CS, Chiu CL, Cooke DT, Brown LM, Melnikow J, Kelly K, Canter RJ.

J Thorac Oncol. 2017 Mar;12(3):437-445. doi: 10.1016/j.jtho.2016.11.2221. Epub 2017 Jan 18.

25.

Cardiac Dose and Survival After Stereotactic Body Radiotherapy for Early-stage Non-Small-cell Lung Cancer.

Tembhekar AR, Wright CL, Daly ME.

Clin Lung Cancer. 2017 May;18(3):293-298. doi: 10.1016/j.cllc.2016.12.007. Epub 2016 Dec 22.

26.

Multi-Institutional Experience of Stereotactic Ablative Radiation Therapy for Stage I Small Cell Lung Cancer.

Verma V, Simone CB 2nd, Allen PK, Gajjar SR, Shah C, Zhen W, Harkenrider MM, Hallemeier CL, Jabbour SK, Matthiesen CL, Braunstein SE, Lee P, Dilling TJ, Allen BG, Nichols EM, Attia A, Zeng J, Biswas T, Paximadis P, Wang F, Walker JM, Stahl JM, Daly ME, Decker RH, Hales RK, Willers H, Videtic GM, Mehta MP, Lin SH.

Int J Radiat Oncol Biol Phys. 2017 Feb 1;97(2):362-371. doi: 10.1016/j.ijrobp.2016.10.041. Epub 2016 Nov 2.

PMID:
28011047
27.

Clinical Impact of Frequent Surveillance Imaging in the First Year Following Chemoradiation for Locally Advanced Non-small-cell Lung Cancer.

Ho QA, Harandi NK, Daly ME.

Clin Lung Cancer. 2017 Jul;18(4):410-414. doi: 10.1016/j.cllc.2016.11.010. Epub 2016 Nov 21.

28.

Multidisciplinary Care.

Daly ME, Riess JW.

Cancer Treat Res. 2016;170:285-300. doi: 10.1007/978-3-319-40389-2_13. Review.

PMID:
27535399
29.

Prognostic Value of p16 Status on the Development of a Complete Response in Involved Oropharynx Cancer Neck Nodes After Cisplatin-Based Chemoradiation: A Secondary Analysis of NRG Oncology RTOG 0129.

Galloway TJ, Zhang QE, Nguyen-Tan PF, Rosenthal DI, Soulieres D, Fortin A, Silverman CL, Daly ME, Ridge JA, Hammond JA, Le QT.

Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2):362-371. doi: 10.1016/j.ijrobp.2016.05.026. Epub 2016 May 28.

30.

Local Radiation for Extensive Stage Small Cell Lung Cancer: A Step Forward or Running in Place?

Daly ME, Lara PN Jr.

Clin Lung Cancer. 2016 Jul;17(4):237-8. doi: 10.1016/j.cllc.2016.06.001. No abstract available.

PMID:
27346548
31.

Clinical Trials Integrating Immunotherapy and Radiation for Non-Small-Cell Lung Cancer.

Daly ME, Monjazeb AM, Kelly K.

J Thorac Oncol. 2015 Dec;10(12):1685-93. doi: 10.1097/JTO.0000000000000686. Review.

32.

Comparison of Toxicity Between Intensity-Modulated Radiotherapy and 3-Dimensional Conformal Radiotherapy for Locally Advanced Non-small-cell Lung Cancer.

Ling DC, Hess CB, Chen AM, Daly ME.

Clin Lung Cancer. 2016 Jan;17(1):18-23. doi: 10.1016/j.cllc.2015.07.006. Epub 2015 Aug 3.

33.

Primary Surgery vs Chemoradiation Treatment of Advanced-Stage Hypopharyngeal Squamous Cell Carcinoma.

Harris BN, Biron VL, Donald P, Farwell DG, Luu QC, Bewley AF, Chen AM, Daly ME.

JAMA Otolaryngol Head Neck Surg. 2015 Jul;141(7):636-40. doi: 10.1001/jamaoto.2015.0659.

PMID:
25973578
34.

Risk of Pneumonitis After Stereotactic Body Radiation Therapy in Patients With Previous Anatomic Lung Resection.

Hayes JT, David EA, Qi L, Chen AM, Daly ME.

Clin Lung Cancer. 2015 Sep;16(5):379-84. doi: 10.1016/j.cllc.2015.01.006. Epub 2015 Jan 31.

35.

Enhanced surface dose via fine brass mesh for a complex skin cancer of the head and neck: report of a technique.

Daly ME, Chen AM, Mayadev JS, Stern RL.

Pract Radiat Oncol. 2015 Jan-Feb;5(1):16-20. doi: 10.1016/j.prro.2014.03.002. Epub 2014 Apr 16.

PMID:
25413387
36.

Level IB nodal involvement in oropharyngeal carcinoma: implications for submandibular gland-sparing intensity-modulated radiotherapy.

Yu Y, Daly ME, Farwell DG, Luu Q, Gandour-Edwards R, Donald PJ, Chen AM.

Laryngoscope. 2015 Mar;125(3):608-14. doi: 10.1002/lary.24907. Epub 2014 Sep 12.

PMID:
25215891
37.

Does early posttreatment surveillance imaging affect subsequent management following stereotactic body radiation therapy for early-stage non-small cell lung cancer?

Daly ME, Beckett LA, Chen AM.

Pract Radiat Oncol. 2014 Jul-Aug;4(4):240-6. doi: 10.1016/j.prro.2013.08.006. Epub 2013 Oct 8.

38.

Quantification of gross tumour volume changes between simulation and first day of radiotherapy for patients with locally advanced malignancies of the lung and head/neck.

Kishan AU, Cui J, Wang PC, Daly ME, Purdy JA, Chen AM.

J Med Imaging Radiat Oncol. 2014 Oct;58(5):618-24. doi: 10.1111/1754-9485.12196. Epub 2014 Jun 18.

PMID:
24942938
39.

Dose--volume modeling of brachial plexus-associated neuropathy after radiation therapy for head-and-neck cancer: findings from a prospective screening protocol.

Chen AM, Wang PC, Daly ME, Cui J, Hall WH, Vijayakumar S, Phillips TL, Farwell DG, Purdy JA.

Int J Radiat Oncol Biol Phys. 2014 Mar 15;88(4):771-7. doi: 10.1016/j.ijrobp.2013.11.244.

PMID:
24606846
40.

Competing causes of death and medical comorbidities among patients with human papillomavirus-positive vs human papillomavirus-negative oropharyngeal carcinoma and impact on adherence to radiotherapy.

Hess CB, Rash DL, Daly ME, Farwell DG, Bishop J, Vaughan AT, Wilson MD, Chen AM.

JAMA Otolaryngol Head Neck Surg. 2014 Apr;140(4):312-6. doi: 10.1001/jamaoto.2013.6732.

41.

Comparison of functional outcomes and quality of life between transoral surgery and definitive chemoradiotherapy for oropharyngeal cancer.

Chen AM, Daly ME, Luu Q, Donald PJ, Farwell DG.

Head Neck. 2015 Mar;37(3):381-5. doi: 10.1002/hed.23610. Epub 2014 Apr 3.

PMID:
24431059
42.

Quality of life among long-term survivors of head and neck cancer treated by intensity-modulated radiotherapy.

Chen AM, Daly ME, Farwell DG, Vazquez E, Courquin J, Lau DH, Purdy JA.

JAMA Otolaryngol Head Neck Surg. 2014 Feb;140(2):129-33. doi: 10.1001/jamaoto.2013.5988.

PMID:
24337483
43.

Long-term experience with reduced planning target volume margins and intensity-modulated radiotherapy with daily image-guidance for head and neck cancer.

Chen AM, Yu Y, Daly ME, Farwell DG, Benedict SH, Purdy JA.

Head Neck. 2014 Dec;36(12):1766-72. doi: 10.1002/hed.23532. Epub 2014 Mar 25.

PMID:
24174221
44.

Observation versus neck dissection for positron-emission tomography-negative lymphadenopathy after chemoradiotherapy.

Khodayari B, Daly ME, Bobinski M, Farwell DG, Shelton DK, Chen AM.

Laryngoscope. 2014 Apr;124(4):902-6. doi: 10.1002/lary.24411. Epub 2013 Oct 22.

PMID:
24115118
45.

Clinical outcomes among patients with head and neck cancer treated by intensity-modulated radiotherapy with and without adaptive replanning.

Chen AM, Daly ME, Cui J, Mathai M, Benedict S, Purdy JA.

Head Neck. 2014 Nov;36(11):1541-6. doi: 10.1002/hed.23477. Epub 2014 Jan 22.

PMID:
23996502
46.

Feasibility and toxicity of concurrent chemoradiation for elderly patients with head and neck cancer.

Daly ME, Lau DH, Farwell DG, Luu Q, Donald PJ, Chen AM.

Am J Otolaryngol. 2013 Nov-Dec;34(6):631-5. doi: 10.1016/j.amjoto.2013.07.010. Epub 2013 Aug 15.

PMID:
23954137
47.

Depression among long-term survivors of head and neck cancer treated with radiation therapy.

Chen AM, Daly ME, Vazquez E, Courquin J, Luu Q, Donald PJ, Farwell DG.

JAMA Otolaryngol Head Neck Surg. 2013 Sep;139(9):885-9. doi: 10.1001/jamaoto.2013.4072.

PMID:
23949013
48.

Definitive radiation therapy without chemotherapy for human papillomavirus-positive head and neck cancer.

Chen AM, Zahra T, Daly ME, Farwell DG, Luu Q, Gandour-Edwards R, Vaughan AT.

Head Neck. 2013 Nov;35(11):1652-6. doi: 10.1002/hed.23209. Epub 2013 Jan 17.

49.

Patterns-of-care for thoracic stereotactic body radiotherapy among practicing radiation oncologists in the United States.

Daly ME, Perks JR, Chen AM.

J Thorac Oncol. 2013 Feb;8(2):202-7. doi: 10.1097/JTO.0b013e318279155f.

50.

Racial disparities in the use of voice preservation therapy for locally advanced laryngeal cancer.

Hou WH, Daly ME, Lee NY, Farwell DG, Luu Q, Chen AM.

Arch Otolaryngol Head Neck Surg. 2012 Jul;138(7):644-9. doi: 10.1001/archoto.2012.1021.

PMID:
22801888

Supplemental Content

Loading ...
Support Center